Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
HIGHLIGHTS: Stable BPC-157, a novel anti-ulcer peptide (1) BPC-157: Healing in different tissues Tendon Healing (4) Bone healing BPC-157 & Neuroprotective effect Effect on Spinal Cord Injury Blood Pressure Tendon Healing (4) Bone healing Stable BPC-157 as anti-ulcer agent (1) Stable gastric pentadecapeptide BPC 157 is a novel anti-ulcer peptide, used in trials for the treatment of ulcerative colitis and now multiple sclerosis, lethal dose (dosage required to kill 1% of the test population, LD1) not reported
New England Journal of Medicine , NEJMoa2511774
(2006), proposed BPC 157 as an effective treatment that could improve muscle healing, when administered despite corticosteroid treatment, 6a-methylprednisolone, following gastrocnemius muscular injury
Limited Clinical Trials : If you are seeking a new indication (e.g., sleep apnea), the FDA will likely require a Phase 3 trial, but you can bypass the Phase 1 and Phase 2 safety stages, saving years and millions in capital
Data from the U.S
You can log into the Aetna member website and contact the help centre through live chat, phone, or email
